Towards using a full spectrum of early clinical trial data: a retrospective analysis to compare potential longitudinal categorical models for molecular targeted therapies in oncology

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0258|34|22|2999-3016

ISSN： 0277-6715

Source： STATISTICS IN MEDICINE, Vol.34, Iss.22, 2015-09, pp. : 2999-3016

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Network meta‐analysis of longitudinal data using fractional polynomials

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 15, 2015-07 ,pp. : 2294-2311

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of clinical trials with biologics using dose–time‐response models

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 22, 2015-09 ,pp. : 3017-3028

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis

By  

STATISTICS IN MEDICINE, Vol. 37, Iss. 6, 2018-03 ,pp. : 867-882

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discrimination of constructed air samples using multivariate analysis of full scan membrane introduction mass spectrometry (MIMS) data

By  

RAPID COMMUNICATIONS IN MASS SPECTROMETRY, Vol. 32, Iss. 4, 2018-02 ,pp. : 349-360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical utility estimation for assay cutoffs in early phase oncology enrichment trials

By  

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 3, 2015-05 ,pp. : 233-341

John Wiley & Sons Inc

Access to resources Recommend Favorite